Tryptamine Therapeutics Sets Date for AGM, Advances Clinical Trials - TipRanks.com

Tryptamine Therapeutics (AU:TYP) announces AGM on Nov 8, 2024, with director nominations closing Sep 27. The biotech firm reports significant progress with TRP-8803 in treating binge eating disorder and explores treatments for fibromyalgia and irritable bowel syndrome.